期刊文献+

水化加前列地尔对老年患者介入术后肾损伤的保护作用 被引量:6

Effect of alprostadil on contrast-induced nephropathy in senile patients after percutaneous coronary intervetition
下载PDF
导出
摘要 目的探讨水化加前列地尔对老年患者PCI术后肾损伤的保护作用及预防对比剂肾病的效果。方法选择老年冠心病患者60例。随机分为2组:对照组26例(常规水化),实验组34例(前列地尔+常规水化)。于PCI术前、术后48h、造影后第7天分别测定血肌酐、血尿素及尿β_2微球蛋白水平。结果与对照组比较,实验组患者PCI术后48h及造影后第7天血肌酐、血尿素和尿β_2微球蛋白明显降低,差异有统计学意义(P<0.05)。实验组患者对比剂肾病2例,发生率为5.9%;对照组对比剂肾病3例,发生率为11.5%,实验组对比剂肾病发生率明显低于对照组,差异有统计学意义(P<0.05)。结论在水化基础上,PCI术前使用前列地尔注射液可明显改善老年患者术后的肾脏功能,明显降低对比剂肾病的发生率。 Objective To explore the efficacy of alprostadil in protection of renal function and in the prevention of contrast-induced nephropathy (CIN) in senile patients who underwent PCI. Methods Sixty senile patients were randomly divided into 2 groups. In the control group (n =26), the patients only accepted routine hydration treatment by intravenous infusion of 0.9 % sodium chloride solution. In the experimental group, besides the hydration treatment, the patients also accepted intravenous infusion of alprostadil injection 30 rain before the PCI in 20 μg,qd,continually for 3 days. Scr,BU,and urine 132 microglobulin were detected before PCI,and 48 hours,7 days after PCI in all patients. Results According to the lab examinations at 48 hours and 7 days after PCI,the renal functions of the patients in the experimental group were significantly better than those in the control group,their Scr and BU returned to normal level. The incidence of CIN in the experimental group was significantly less than that in the control group, there were 2 cases of CIN (5. 9%) in the experimental group, while in the control group there were 3 cases of CIN (11.5%) ,the difference between the two groups had statistical significance (P (0.05). Conclusion Compared with treatment with hydration only, application of alprostadil injection before PCI could obviously improve the renal functions of the senile patients, and significantly decrease the incidence of contrast-induced nephropathy.
机构地区 解放军第三
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2011年第4期344-346,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 肾病 尿素 肾功能不全 Β2微球蛋白 前列地尔 nephrosis urea renal insufficiency beta 2-mieroglobulin alprostadil
  • 相关文献

参考文献9

  • 1Dangas G, Iakovou I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol, 2005,95 : 13-19.
  • 2Laville M, Juillard L. Contrast-induced acute kidney injury: how should at risk patients be identified and managed? J Nephrol, 2010,23 : 387-398.
  • 3Zoungas S, Ninomiya T, Huxley R, et al. Systematic review:sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med, 2009, 151: 631- 638.
  • 4Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 2002,105 : 2259-2264.
  • 5张翩,倪兆慧,王玲,何奔,王肖龙,邱建平,郑昌柱,杨光敏,朱爱国.多中心住院心内科冠状动脉造影患者造影剂肾病发生情况[J].中国血液净化,2010,9(7):375-379. 被引量:10
  • 6Tumlin J,Stacul F,Adam A,et al. Pathophysiology of contrastinduced nephropathy. Am J Cardiol, 2006,98 : 14K-20K.
  • 7Solomon R. Preventing contrast-induced nephropathy: problems, challenges and future directions. BMC Med, 2009,7 : 24.
  • 8Sketch MH Jr,Whelton A,Schollmayer E,et al. Prostaglandin E1 Study Group: Prevention of contrast media-induced renal dysfunction with prostaglandin E l:a randomized,double-blind, placebo controlled study. Am J Ther, 2001,8 : 155-162.
  • 9叶云,杨宇,韩卓辉,刘军.前列地尔脂微球载体注射液预防老年人造影剂肾病的临床观察[J].中国新药杂志,2006,15(16):1386-1389. 被引量:8

二级参考文献26

  • 1叶菡洋,袁伟杰,边琪,梅小斌,傅鹏,郭云珊,崔若兰.血管造影术后肾损害的临床相关危险因素探讨[J].中华肾脏病杂志,2006,22(6):375-376. 被引量:6
  • 2Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency[J]. Am J Kidney Dis, 2002,39:930 936.
  • 3Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification[J]. Am J Cardiol, 2004, 93:1515-1519.
  • 4Abe M, Kimura T, Morimoto T, et al. Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients[J]. Circ J, 2009, 73:1518-1522.
  • 5Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergo ing percutaneous coronary interventions[J]. J Am Coil Cardiol, 2002,39:1113-1119.
  • 6Lindsay J, Canos DA, Apple S, et al. Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine[J]. Am J Cardiol, 2004,94:786-789.
  • 7Solomon RJ, Mehran R, Natarajan MK, et al. Contrastinduced nephropathy and long-term adverse events: Cause and effect?[J]. Clin J Am Soc Nephrol, 2009,4:1162-1169.
  • 8Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy[J]. Catheter Cardiovasc Interv, 2008,71:62- 72.
  • 9Zuo L, Ma YC, Zhou YH, et al. Application of GFR-estimating equations in Chinese patients with chronic kidney disease [J]. Am J Kidney Dis, 2005,45:463-472.
  • 10Lameire N, Adam A, Becker CR, et al. Baseline renal function screening[J]. Am J Cardiol, 2006,98:21K-26K.

共引文献16

同被引文献86

  • 1徐蓉,夏进东,金川连,沈旭峰,毛建强.前列地尔注射液对心功能不全患者冠脉介入术后对比剂肾病的影响[J].医学临床研究,2012,29(6). 被引量:5
  • 2叶云,杨宇,韩卓辉,刘军.前列地尔脂微球载体注射液预防老年人造影剂肾病的临床观察[J].中国新药杂志,2006,15(16):1386-1389. 被引量:8
  • 3Sudarsky D, Nikolsky E. Contrast-induced nephropathy in interventional cardiology [J], Int J Nephrol Renovasc Dis, 2011, 4: 85-99.
  • 4Jo S H, Koo B K, Park J S, et al. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study [J]. Am Heart J, 2008,17(6):616-623.
  • 5Zoungas S, Ninomiya T, Huxley R, et al. Systematic review: sodimn bicarbonate treatment regimens for the prevention of contrast-induced nephropathy [J]. Ann Intern Med, 2009,151 (9) :631-638.
  • 6Dangas G, lakovou 1, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic, kidney disease and hemodynamic variables [J]. Am J Cardiol, 2005,95(1): 13-19.
  • 7Laville M, Juillard L. Contrast-induced acute kidney injury: how should at-risk patients be identified and managed [J]? J Nephrol, 2010,23 (04) : 387-398.
  • 8Sketch M H Jr, Whelton A, Schollmayer E, et al. Prevention of contrast media-induced renal dysfunction with prostaglandin E1 : a randomized, double-blind, placebo-controlled study [J]. Am J Ther, 2001,8(3) : 155-162.
  • 9Gibson CM,Cannon CP,Daley WL,et al.TIMI frame count:a quantitative method of assessing coronary artery flow[J].Circulation,1996,93 (5):879-888.
  • 10Tambe AA,Demany MA,Zimmerman HA,et al.Angina pectoris and slow flow velocity of dye in coronary arteries——a new angiographic finding[J].Am Heart J,1972,84(1):66-71.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部